Indegene Limited
₹587.65-₹6.35 (-1.1%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹12,308 Cr
- P/E
- 58.9x
- EV / EBITDA
- 56.1x
- Revenue
- ₹1,094 Cr
- Net margin
- 13.2%
- ROCE
- 17.0%
Price chart
Technical chartScreen technicals →+6.4% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -0.4%
- 3M
- +14.2%
- 6M
- +17.6%
- 1Y
- +6.4%
- 5Y
- +5.7%
52-week range
Day change -₹6.35 (-1.1%) from ₹594 to ₹588 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in INDGN, bought on each weekday since 2024.
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 25.6%
Concerns1
- Negative free cash flow (₹695 Cr)
Rule-based from financial data. Not advice.
About the company
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies.
Read moreShow less
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
- Sector
- Technology
- Shares outstanding
- 24.1 Cr shares
- ISIN
- INE065X01017
- BSE code
- 544172
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹12,308 Cr
- P/E
- 58.9x
- P/B
- 6.3x
- EV / EBITDA
- 56.1x
- EV / Sales
- 11.7x
- P/S
- 11.8x
- Earnings yield
- 1.7%
- 52-week high
- ₹612.95
- 52-week low
- ₹424.30
Profitability
- Operating margin
- 16.1%
- Net margin
- 13.2%
- EBITDA margin
- 20.8%
- ROE
- 14.5%
- ROCE
- 17.0%
- ROA
- 11.3%
- Dividend payout
- 0.0%
- Tax rate
- 24.0%
- Other income, % of PBT
- 27.6%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹1,094 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 4.6%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 25.6%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹218 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 1.4%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 31.2%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 34.0%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹176 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 114.6%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹22.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 17.5%
Solvency and efficiency
- Current ratio
- 5.11
- Debt / Equity
- 0.04
- Debt / Assets
- 0.03
- Debt / EBITDA
- 0.17
- Interest coverage
- 24.00
- Financial leverage
- 1.28
- CFO / Net profit
- 1.28
- Cash / Market cap
- 4.4%
- Cash per share
- ₹22.42
- Asset turnover
- 0.86
- Fixed asset turnover
- 18.68
- Capital intensity
- 0.05
- Debtor days
- 132 days
- Cash conversion cycle
- 132 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹17 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹914 Cr |
| Sales | Operating profit | ₹180 Cr |
| Operating profit | Interest | ₹6 Cr |
| Operating profit | Depreciation | ₹26 Cr |
| Operating profit | Profit before tax | ₹148 Cr |
| Other income | Profit before tax | ₹90 Cr |
| Profit before tax | Tax and other | ₹57 Cr |
| Profit before tax | Net profit | ₹181 Cr |
Revenue and net profit
Revenue grew 4.6% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹511 Cr | ₹132 Cr |
| FY2022 | ₹837 Cr | ₹133 Cr |
| FY2023 | ₹1,006 Cr | ₹130 Cr |
| FY2024 | ₹1,046 Cr | ₹138 Cr |
| FY2025 | ₹1,094 Cr | ₹181 Cr |
Cash flows
FY2025: ₹129 Cr from operations, -₹695 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹53 Cr | ₹19 Cr |
| FY2022 | ₹38 Cr | -₹229 Cr |
| FY2023 | ₹82 Cr | ₹31 Cr |
| FY2024 | ₹176 Cr | -₹13 Cr |
| FY2025 | ₹129 Cr | -₹695 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹1,094 Cr+4.6%1Y
- Net profit
- ₹181 Cr+31.2%1Y
- Cash from operations
- ₹129 Cr
- Free cash flow
- -₹695 Cr
- Revenue CAGR, 5Y
- 25.6%
- EBITDA CAGR, 5Y
- 28.6%
- Net profit CAGR, 5Y
- 34.0%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹1,094 Cr | ₹180 Cr | — | ₹181 Cr | ₹129 Cr | -₹695 Cr | 9.6% | +4.6% | +31.2% |
Monthly returns
Month-by-month returns of INDGN across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹2,150 Cr |
| Equity capital | ₹48 Cr |
| Reserves | ₹1,840 Cr |
| Borrowings | ₹27 Cr |
| Other liabilities | ₹234 Cr |
| Assets | ₹2,150 Cr |
| Fixed assets | ₹53 Cr |
| Capital work in progress | ₹4 Cr |
| Investments | ₹975 Cr |
| Other assets | ₹1,119 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
INDGN trades at 58.9x earnings against a peer median of 52.1x (a 13% premium).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Indegene LimitedINDGNthis companyP/E ↑ premium | ₹12,308 Cr | 58.9x | 6.3x | 14.5% | 56.1x |
| Concord Biotech LimitedCONCORDBIO | ₹14,122 Cr | 43.9x | 7.8x | 20.0% | 30.0x |
| CarTrade Tech LimitedCARTRADE | ₹13,418 Cr | 138.0x | 6.0x | 2.0% | 216.1x |
| Cyient LimitedCYIENT | ₹13,048 Cr | 29.8x | 3.4x | 16.9% | 16.6x |
| INTELLECT DESIGN ARENA LIMITEDINTELLECT | ₹12,976 Cr | 52.1x | 6.6x | 9.4% | 35.5x |
| BIRLASOFT LIMITEDBSOFT | ₹11,840 Cr | 43.0x | 7.1x | 20.4% | 24.6x |
| Zen Technologies Ltd.ZENTEC | ₹11,156 Cr | 53.9x | 6.3x | 28.5% | 57.2x |
| Newgen Software Technologies LimitedNEWGEN | ₹11,084 Cr | 35.7x | 7.5x | 20.6% | 34.8x |
| WAAREE RENEWABLE TECHNOLOGIES LIMITEDWAAREERTL | ₹10,499 Cr | 29.6x | 15.9x | 58.5% | 49.4x |
| Peer median | — | 52.1x | 7.8x | 14.5% | 34.2x |
Year-to-date ROI
INDGN since 1 January, against earlier years.
Historical volatility
INDGN's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 29.0% |
| FY2022 | 20.0% |
| FY2023 | 18.0% |
| FY2024 | 16.0% |
| FY2025 | 17.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹1,094 Cr |
| Costs | |
| Interest | ₹6 Cr |
| Expenses | ₹913 Cr |
| Operating profitOperating Profit | ₹180 Cr |
| Other income and charges | |
| Profit before tax | ₹238 Cr |
| Tax | |
| Net profitNet Profit | ₹181 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹2,150 Cr |
| Equity capitalEquity Capital | ₹48 Cr |
| Reserves | ₹1,840 Cr |
| Borrowings | ₹27 Cr |
| Other liabilitiesOther Liabilities | ₹234 Cr |
| AssetsTotal Assets | ₹2,150 Cr |
| Fixed assetsFixed Assets | ₹53 Cr |
| Capital work in progressCWIP | ₹4 Cr |
| Investments | ₹975 Cr |
| Other assetsOther Assets | ₹1,119 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹129 Cr |
| Investing cash flowCash from Investing Activity | -₹824 Cr |
| Financing cash flowCash from Financing Activity | ₹717 Cr |
| Change in cashNet Cash Flow | ₹22 Cr |
Learn while you research
Academy chapters picked for Indegene Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 58.9, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Growth InvestingTech & communications often trade on growth, learn the framework.7 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read